J Antimicrob Chemother 2007, 59:751–5744.PubMedCrossRef 31. Park CH, Rovicsek A, Jacoby GA, Sahm D, Hooper DC: Prevalence in the United States of aac(6)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50:3953–3955.PubMedCrossRefPubMedCentral Alvespimycin 32. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P: Emergence of plasmid-mediated quinolone resistance in 4SC-202 solubility dmso Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49:71–76.PubMedCrossRefPubMedCentral 33. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla EP: Comparative study of mutations in animal isolates and experimental in-vitro and in-vivo mutation of Salmonella
spp . suggests a counter selection of highly fluoroquinolone resistant strains in the field. Antimicrob Agents Chemother 1999, 43:2131–2137.PubMedPubMedCentral 34. Mazel D, Dychinco B, Webb VA, Davies J: Antibiotic resistance in the ECOR collection: Integrons and identification of
a novel aad gene. Antimicrob Agents Chemother 2000, 44:1568–1574.PubMedCrossRefPubMedCentral 35. Sánez Y, Briñas L, Domínguez E, Zarazaga M, Vila J, Torres C: Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 2004, 48:3996–4001.CrossRef 36. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM: The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, Enzalutamide datasheet in both community-onset and hospital-acquired infections Baricitinib in Thailand. Diagn Microbiol Infect Dis 2007, 58:349–355.PubMedCrossRef 37. Ribot FM, Fair NA, Gautom R, Carmeron DN, Hunter SB, Swaminathan B, Barrett TJ: Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157, Salmonella and Shigella for pulsenet. Foodborne Pathog Dis 2006, 3:59–67.PubMedCrossRef 38. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL,
Threlfall EJ: Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219–228.PubMedCrossRef 39. Mshana SE, Imirzalioglu C, Hossain H, Hain T, Domann E, Chakraborty T: Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC Infect Dis 2009, 9:97. doi:10.1186/1471-2334-9-97.PubMedCrossRefPubMedCentral 40. Khan MA, Lemmens N, Riera E, Blonk T, Goedhart J, Van Belkum A, Goessens W, Hays JP, Van Westreenen M: Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum β-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay. J Antimicrob Chemother 2009, 64:1330–1332.PubMedCrossRef 41. Suzuki S, Shibata N, Yamane K, Wachino JI, Ito K, Arakawa Y: Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72–79.PubMedCrossRef 42.